Skip to main content

Advertisement

Table 1 Baseline demographics of patients in the metformin and insulin group

From: Metformin or insulin: logical treatment in women with gestational diabetes in the Middle East, our experience

  Metformin (58) Met+ Ins (32) Insulin (17)
Average age in years (range) 32 (22–42) 34 (25–45) 34 (20–46)
 20–40 56 (96.6%) 28 (87.5%) 14 (82.4%)
 41+ 2 (3.4%) 4 (12.5%) 3 (17.6%)
Average parity (range) 2 (0–9) 2 (0–5) 2 (0–6)
 Nulliparity 13 (22.4%) 2 (6.3%) 5 (29.4%)
 1–4 42 (72.4%) 29 (90.6%) 11 (64.7%)
 5+ 3 (5.2%) 1 (3.1%) 1 (5.9%)
Ethnicity
 Middle Eastern 3 (5.2%) 6 (18.7%) 7 (41.2%)
 Rest of Asia 45 (77.6%) 19 (59.4%) 6 (35.3%)
 Africa 10 (17.2%) 7 (21.9%) 4 (23.5%)
Average BMI in kg/m2 (range) 30 (23–41) 32 (23–52) 35 (23–53)
 18.5–24.9 4 (6.9%) 2 (6.3%) 1 (5.9%)
 25–29.9 22 (37.9%) 12 (37.5%) 2 (11.7%)
 30–34.9 26 (44.8%) 7 (21.9%) 6 (35.3%)
 > 35 6 (10.4%) 11 (34.3%) 8 (47.1%)